Synthesis and antiproliferative action of a novel series of maprotiline analogues
![Thumbnail](/themes/Mirage2/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
Journal ArticleDate:
2014Access:
OpenAccessCitation:
McNamara, Y. M. Bright, S. A. Byrne, A. J. Cloonan, Suzanne M. McCabe, T. Williams, D. C. Meegan, M. J., Synthesis and antiproliferative action of a novel series of maprotiline analogues, European Journal of Medicinal Chemistry, 2014Abstract:
The synthesis of a diverse library of compounds structurally related to maprotiline, a norepinephrine reuptake transporter (NET) selective antidepressant which has recently been identified as a novel in vitro antiproliferative agent against Burkitt?s lymphoma (BL) cell lines is reported. A series of 9,10-dihydro-9,10-ethanoanthracenes was synthesised with modifications to the bridge of the dihydroethanoanthracene structure and with alterations to the basic side chain. A number of compounds were found to reduce cell viability to a greater extent than maprotiline in BL cell lines. In addition a related series of novel 9- substituted anthracene compounds was investigated as intermediates in the synthesis of 9,10-dihydro-9,10-ethanoanthracenes. These compounds proved the most active from the screen and were found to exert a potent caspase-dependant apoptotic effect in the BL cell lines, while having minimal effect on the viability of peripheral blood mononuclear Cells (PBMCs). Compounds also displayed activity in multi-drug resistant (MDR) cells.
Author's Homepage:
http://people.tcd.ie/mmeeganhttp://people.tcd.ie/tmccabe
Description:
PUBLISHED
Author: MEEGAN, MARY; MCCABE, THOMAS
Type of material:
Journal ArticleSeries/Report no:
European Journal of Medicinal ChemistryAvailability:
Full text availableKeywords:
Burkitt?s lymphomaMetadata
Show full item recordLicences: